15th Annual Scottsdale Prostate Cancer Symposium 2010 March 4-7, 2010 Camelback Inn, A JW Marriott Resort and Spa Scottsdale, Arizona

About the Program World renown experts in prostate cancer will provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease. Topics of discussion will include Robotic Prostatectomy, Cryoablation, Brachytherapy, IMGT/IGRT, High-Intensity Focused Ultrasound (HIFU), Mapping Biopsy, Pathology Update, Noval Markers, Systemic Therapy and Nutricals. Target Audience Urologists, Radiation Oncologists, Medical Oncologists, Physicists, and other health care professionals. Course Objectives At the conclusion of this activity, participants will be able to: • Describe technical presentations and advances of robotic radical prostatectomy, image-guided external beam radiotherapy, computer-guided brachytherapy, cryoablation, and high-intensity focused ultrasound (HIFU) of the prostate. • Recognize the role of new prognostic agents in diagnosis and management of prostate cancer. • Describe the new techniques of real-time, dose moderated brachytherapy, robotic prostatectomy and HIFU. • Identify appropriate patients for brachytherapy IMRT-IGRT, robotic and open prostectomy, HIFU and salvage therapies. • Recognize potential benefits of chemotherapy in patients with locally advanced and hormone refractory prostate cancer. • Identify the role of bone health agents in advanced prostate cancer. • Explain the use of nutritional supplements (nutricals) in men with prostate cancer.   Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Diversified Conference Management, Inc. (DCMI). PIM is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this educational activity for a maximum of 20.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. . Jointly Sponsored by Postgraduate Institute for Medicine and Diversified Conference Management, Inc.       This activity is supported by multiple educational grants.   Home | About Us | Contact Prostate | Faculty | Agenda | Information | Exhibit Application | Hotel | Registration   Copyright ©2001. All Rights Reserved. Last Revised 11-1-09